Skip to Content
Merck
All Photos(3)

Documents

840058P

Avanti

Hydro Soy PC

Avanti Research™ - A Croda Brand

Synonym(s):

HSPC

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

CAS Number:
97281-48-6
UNSPSC Code:
12352211
NACRES:
NA.25

description

L-α-phosphatidylcholine, hydrogenated (Soy)

Assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 g (840058P-1g)
pkg of 1 × 200 mg (840058P-200mg)
pkg of 1 × 25 mg (840058P-25mg)
pkg of 1 × 500 mg (840058P-500mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand

lipid type

phospholipids
phosphoglycerides

shipped in

dry ice

storage temp.

−20°C

InChI

1S/C44H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h42H,6-41H2,1-5H3/t42-/m1/s1

InChI key

NRJAVPSFFCBXDT-HUESYALOSA-N

Application

L-α-phosphatidylcholine, hydrogenated (Soy) may be used in the lipososme generation for reconstitution of complement active human plasma, bupivacaine and dexamethasone loading.

Biochem/physiol Actions

L-α-phosphatidylcholine, hydrogenated (Soy) is naturally occurring and is majorly used in the synthesizing liposomes. It is also used in small unilamellar vesicles (SUVs) synthesis.

Packaging

30 mL Amber Wide Mouth Bottle with Screw Cap (840058P-500mg)
5 mL Amber Glass Screw Cap Vial (840058P-200mg)
5 mL Amber Glass Screw Cap Vial (840058P-25mg)
60 mL Amber Wide Mouth Screw Cap Glass Bottle (840058P-1g)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

also commonly purchased with this product

Product No.
Description
Pricing

Storage Class Code

11 - Combustible Solids

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes
Graham SM, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society, 178(10), 101-107 (2014)
Ankita Dadwal et al.
Journal of microencapsulation, 1-14 (2020-04-16)
Aim: The aim of this project is to improve the therapeutic effectiveness, permeation and retention of clobetasol propionate in sebaceous glands by reporting the use of Squarticles as lipidic nanosystem.Methods: Homogenisation method is used for the formulation of Squarticles (nanoemulgel)
Nikolaos Naziris et al.
International journal of pharmaceutics, 574, 118849-118849 (2019-11-24)
The utilization of liposomes in biomedical applications has greatly benefited the diagnosis and treatment of various diseases. These biomimetic nano-entities have been very useful in the clinical practice as drug delivery systems in their conventional form, comprising lipids as structural
alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy
Davis MS, et al
Journal of Inflammation Research, 12(10), 87-87 (2019)
Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization
Lin TW, et al.
International Journal of Molecular Sciences, 20(2), 241-241 (2019)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service